Ticlopidine,Alka-Seltzer®,or a Combination of Citric Acid With Aspirin: Effects on Platelet Aggregation in Individuals With an Insufficient Response to Aspirin Alone

Abstract

Aspirin (ASA) does not effectively lower platelet aggregation in all people. The platelet aggregation (PA) score is an easily used clinical method for measuring the effect in individuals of antiplatelet medications. Fifteen apparently healthy subjects (2 men and 13 women), selected for their resistance to ASA's antiaggregation effect, completed a se quential trial of ticlopidine, Alka-Seltzer®, and ASA + citric acid (CTA). Ticlopidine was the strongest aggregation inhibitor and the ASA + CTA combination was more inhibitory than Alka-Seltzer. It was determined that measuring antiaggregation effects of a particular agent in an individual prior to usage would optimize treatment. The PA score methodology provides a means for testing patients prior to antiplatelet therapy for prevention and treatment of the thrombotic complications of vascular disease.

Keywords

Key Words: Platelet aggregation inhibitors Aspirin Thrombosis

References

Kaplan A. , Kaplan S. , Marcoe KF , Sauvage LR , Hammond WP Modified technique for measuring platelet aggregation. Clin Appl Thrombosis/Hemostasis 1997;3:196.

Saad EM , Kaplan S. , El-Massry S. , et al. Platelet aggregometry can accurately predict failure of externally supported knitted Dacron femoropopliteal bypass grafts. J Vasc Surg 1993;18:587.

Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330:1287.

Kaplan S. , Kaplan A. , Marcoe KF , Hammond WP , Fisher LD , Sauvage LR Citric acid enhances the antithrombotic effect of aspirin in many aspirin-resistant subjects. Clin Appl Thrombosisl Hemostasis 1997;3:54.

Kaplan S. , Kaplan A. , Marcoe KF , et al. The platelet aggregation score and its correlation to β-thromboglobulin and platelet factor 4 levels. Clin Appl Thrombosis/Hemostasis 1995;1:135.

Ray LI , Matsuzaki T. , Rodriguez-Lopez J. , Lopez-Galarza L. , Tarlian H. , Diethrich EB The PA score: a new risk factor for predicting adverse events in peripheral arterial interventions. J Endovasc Surg 1996 ;3:117.

Bennett CL , Weinberg PD , Rozenberg-Ben Dror K, Yarnold PR, Kwaan HC, Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine. Ann Intern Med 1998;128:541.